Ovry provides ultra-sensitive at-home pregnancy test strips that detect hCG up to six days before a missed period. These FDA-cleared tests offer over 99.7% accuracy with a low detection threshold, enabling earlier confirmation and planning.
Funding
Funding not disclosed
Founders
Product
Problem
Individuals seeking early pregnancy detection often face limitations with standard tests that provide results only after a missed period. This delay can cause anxiety and prevent timely planning or medical consultation.
Solution
Ovry offers ultra-sensitive at-home pregnancy test strips designed for early detection, capable of identifying pregnancy up to six days before a missed period. These tests utilize a low detection threshold for Human Chorionic Gonadotropin (hCG), providing results with over 99.7% accuracy. The product line emphasizes discreet packaging and eco-friendly materials, aiming to reduce waste associated with traditional plastic-handled tests. Ovry also incorporates a social impact model, donating a portion of sales to women's health and rights organizations.
Target Audience
The primary customers are individuals seeking to confirm pregnancy as early as possible, including those actively trying to conceive or requiring prompt confirmation for personal or medical reasons.
Features
- Ultra-sensitive immunoassay for hCG detection with a sensitivity threshold of 10 mIU/mL.
- Over 99.7% accuracy rate when used from the day of the expected period.
- Capable of detecting pregnancy up to six days before a missed period.
- Discreet, unbranded packaging for privacy.
- Eco-friendly design utilizing recyclable materials and minimizing plastic waste.
- Available in multiple pack sizes (4, 10, and 18 tests) with a reusable sample cup included.
- Long shelf life of 24 months from the manufacturing date.
- FDA-Cleared and compliant with US and Canadian regulatory requirements.